New ICER and PHIL data show drug launch prices soaring while patients, especially on Medicare, struggle to access needed care ...

Dren Bio has closed an oversubscribed $350 million private financing round to advance its lead antibody candidate toward ...

Astellas secures option to license Audax's IL-12 immuno-oncology candidate in a deal worth up to $1.34 billion.

Recent court rulings and USPTO guidance reshape how biotech startups should approach patent strategy for drugs and ...

Flagship has merged 3 of its own portfolio companies into a single powerhouse aimed at predicting how drugs will work before ...

A ten-member European consortium led by Exogenus Therapeutics has secured $14.4 million to develop a disease-modifying ...

Ferring Pharmaceuticals is set to acquire Gameto, a cell engineering company working on new fertility treatments.

EUCROF says the upcoming Ukrainian CRO Association will help show the country remains a strong location for drug trials ...

A recent panel of finance leaders said that companies should stop thinking about fundraising as a last-minute response to ...

Intellectual property enforcement in the life sciences sector is evolving rapidly overall, and in no small part due to ...

Hematology research now needs new evidence strategies as targeted therapies create smaller, more specialized patient groups today ...

Anthropic, the AI lab behind Claude, has filed to go public on Nasdaq under ticker "ANT," though key offering details remain undisclosed.